These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1238 related articles for article (PubMed ID: 27092879)

  • 1. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
    Chen M; Li L; Zheng PS
    Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt/β-catenin signaling pathway.
    Chen Q; Cao HZ; Zheng PS
    Oncotarget; 2014 Oct; 5(19):9092-105. PubMed ID: 25193857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt/β-catenin pathway via GSK3β.
    Liu XF; Li XY; Zheng PS; Yang WT
    Cell Death Dis; 2018 Mar; 9(3):339. PubMed ID: 29497051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
    Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
    Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.
    Chen JF; Luo X; Xiang LS; Li HT; Zha L; Li N; He JM; Xie GF; Xie X; Liang HJ
    Oncotarget; 2016 Jul; 7(27):41540-41558. PubMed ID: 27172794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
    Li L; Yang WT; Zheng PS; Liu XF
    Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
    Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
    EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXA5 inhibits the proliferation and neoplasia of cervical cancer cells via downregulating the activity of the Wnt/β-catenin pathway and transactivating TP53.
    Ma HM; Cui N; Zheng PS
    Cell Death Dis; 2020 Jun; 11(6):420. PubMed ID: 32499530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
    Cai L; Wang Z; Liu D
    Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of EZH2 by RNA interference inhibits proliferation and invasion of ACHN cells via the Wnt/β- catenin pathway.
    Yuan JB; Yang LY; Tang ZY; Zu XB; Qi L
    Asian Pac J Cancer Prev; 2012; 13(12):6197-201. PubMed ID: 23464430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of EZH2 genes targeting RUNX3 affects proliferation, invasion, and metastasis of human colon cancer cells by Wnt/β-catenin signaling pathway.
    Liang G; Han L; Qu M; Xue J; Xu D; Wu X; Lu Y
    Aging (Albany NY); 2023 Dec; 15(23):13655-13668. PubMed ID: 38048186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway.
    Zhang JJ; Chen JT; Hua L; Yao KH; Wang CY
    Biomed Pharmacother; 2017 Jan; 85():472-478. PubMed ID: 27890434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 promotes cell proliferation by regulating the expression of RUNX3 in laryngeal carcinoma.
    Lian R; Ma H; Wu Z; Zhang G; Jiao L; Miao W; Jin Q; Li R; Chen P; Shi H; Yu W
    Mol Cell Biochem; 2018 Feb; 439(1-2):35-43. PubMed ID: 28795320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
    Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
    Hsu W; Liu L; Chen X; Zhang Y; Zhu W
    Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
    Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
    Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator.
    Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX
    Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.